The data have a story to tell. We can help.
Brod M, Christenson T, Bushnell DM. J Med Econ. 2012;15(1):77-86. Impact of Nocturnal Hypoglycemic Events on Diabetes Management, Sleep Quality, and Next-Day Function: Results from a Four-Country Survey. PMID: 22029460
Lopes M, Rothermel C. CDMI Report. Spring 2012. Pages 24-27. Implications of the Revised Medical Loss Ratio on Managed Care.
American Journal of Managed Care. 2011 Supplement. Improving Treatment Success Rates for Type 2 Diabetes: Balancing Safety, Cost, and Outcome.
Lee WC, Conner C, Hammer M. CMRO. 2011;27(5):897-906. Cost-effectiveness of Liraglutide Versus Rosiglitazone, Both in Combination with Glimepiride in Treatment of Type 2 Diabetes in the US. PMID: 21348806
Niesvizky R, Badros AZ. JCCN. 2010;8(S1):S-13-S20. Complications of Multiple Myeloma Therapy, Part 2: Risk Reduction and Management of Venous Thromboembolism, Osteonecrosis of the Jaw, Renal Complications, and Anemia. PMID: 20141670
Chapman RH, Benner JS, Girase P, et al. Curr Med Res Opin. 2009;25(5):1247-1260. Generic and Therapeutic Statin Switches and Disruptions in Therapy. PMID: 19344292
Yeaw J, Benner JS, Welt JG, et al. J Manag Care Pharm. 2009;15(9):728-740. Comparing Adherence and Persistence Across 6 Chronic Medication Classes. PMID: 19954264
MacLean JR, Chapman RH, Ferrufino CP, et al. Int J Clin Pract. 2009;63(7):1008-1016. Drug Titration Patterns and HbA1c levels in Type 2 Diabetes. PMID: 19570118
Much of our other work is under copyright and cannot be included here. If you would like to see a specific sample, or if you are interested in talking further, please contact us.
Best Practices, Polished and Proofread